A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1998
10/20/1998	US5824782 Immunoconjugates II
10/20/1998	US5824781 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/20/1998	US5824778 Chemically-modified G-CSF
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824685 Vision defects and gene expression
10/20/1998	US5824668 Steroid and cyclodextrin used to treat obesity, diabetes, hpercorticoidism, anemia
10/20/1998	US5824666 Low PH, hydrolytically stable, cosmetic compositions containing acidic actives
10/20/1998	US5824660 Heparin/tissue factor pathway inhibitor for genetic engineering
10/20/1998	US5824658 Topical composition containing hyaluronic acid and NSAIDS
10/20/1998	US5824650 Antiinflammatory agents for skin by applying topically substance p antagonist
10/20/1998	US5824646 Administering calcitonin in combinatin with an adhesion promoter consisting of a nonionic surfactant and saturated aliphatic carboxylic acid
10/20/1998	US5824343 Bioerodible polymers, compositions and therapeutic method
10/20/1998	CA2146565C Compositions for treatment of inflamed tissues
10/20/1998	CA2103163C Compositions and methods for the sublingual or buccal administration of therapeutic agents
10/20/1998	CA2066924C Use of lysine pyrrolidonecarboxylate and(or) arginine pyrrolidonecarboxylate as an antioxidant in pharmaceutical or cosmetic composition
10/17/1998	CA2243983A1 Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
10/15/1998	WO1998045304A1 Trans-platinum compound, and diagnostic kit
10/15/1998	WO1998045284A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/15/1998	WO1998045233A2 Omega-amino acid derivatives, processes of their preparation and their use
10/15/1998	WO1998044952A1 pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
10/15/1998	WO1998044951A2 Hydrolysable delivery system using cross-linked polymeric resins as vehicles
10/15/1998	WO1998044949A1 Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters
10/15/1998	WO1998044944A2 Stabilized human papillomavirus formulations
10/15/1998	WO1998044937A1 Preventive or remedy for kidney diseases
10/15/1998	WO1998044936A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
10/15/1998	WO1998044930A1 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation
10/15/1998	WO1998027963A3 Gel composition and methods
10/15/1998	DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998	DE19715477A1 Production of barium and/or strontium hexa:ferrite magnetic particles
10/15/1998	DE19714450A1 Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung Stable extract of Hypericum perforatum L., process for its preparation and pharmaceutical preparation
10/15/1998	CA2286294A1 Stabilized human papillomavirus formulations
10/15/1998	CA2286064A1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
10/15/1998	CA2285900A1 Prophylactics and remedies for renal diseases
10/15/1998	CA2284625A1 Adhesive for percutaneously absorbable patch and percutaneously absorbable patch
10/14/1998	EP0870781A1 Blockcopolymers and their use as polymeric surfactants
10/14/1998	EP0870757A2 Fluoro-substituted adamantane derivatives
10/14/1998	EP0870500A1 Anti-helicobacter pylori agent
10/14/1998	EP0870019A2 Cell activation process and reagents therefor
10/14/1998	EP0869986A1 Polymers with controlled physical state and bioerodibility
10/14/1998	EP0869819A1 Pharmaceutical compositions with vitamin d analogues
10/14/1998	EP0869818A1 Cytotoxic agents
10/14/1998	EP0869817A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
10/14/1998	EP0869816A1 Dry compositions
10/14/1998	EP0869815A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
10/14/1998	EP0869814A1 Stabilisers for live vaccines
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
10/14/1998	EP0869801A2 Therapeutic and diagnostic agents for the treatment of microbial infections
10/14/1998	EP0869783A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
10/14/1998	EP0869776A1 Stabilised nanoparticles capable of being filtered under sterile conditions
10/14/1998	EP0869714A1 Method for the control of infestations of honeybee colonies
10/14/1998	EP0856312B1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder
10/14/1998	EP0779894A4 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
10/14/1998	EP0750493B1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
10/14/1998	EP0710226B1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products
10/14/1998	EP0689424B1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
10/14/1998	CN1196002A Oil-water emulsifiers
10/14/1998	CN1195995A Transcytosis vehicles and enhancers for drug delivery
10/14/1998	CN1195994A Hormone patch
10/14/1998	CN1195986A Paroxetine controlled release compositions
10/14/1998	CN1195984A Pharmaceutical formulations containing darifenacin
10/14/1998	CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof
10/14/1998	CN1195524A Pharmaceutical formulation
10/14/1998	CN1195523A 组合物 The composition
10/14/1998	CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/13/1998	US5821349 Derivatives of cyclodextrins, their preparation and their use for incorporating hydrophobic molecules into organized surfactant systems
10/13/1998	US5821281 Copolymerizing acrylic or methacrylic acid derivative having drug bonded thereto with additional acrylic monomer in solid phase in absence of solvent under mechanical force
10/13/1998	US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998	US5821221 Drug delivery; sustained release
10/13/1998	US5821220 Method of producing concentrated non-buffered solutions of fibronectin
10/13/1998	US5821081 Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides
10/13/1998	US5821047 Fusing a gene encoding a protein of interest to the carboxy terminal domain of the gene iii coat protein of the filamentous phage m13; mutation to form library; expressed in low quantity on surface of phagemid particle
10/13/1998	US5820882 Biocompatible microcapsules
10/13/1998	US5820873 Polyethylene glycol modified ceramide lipids and liposome uses thereof
10/13/1998	US5820860 Comprises a capsular polysaccharide that elicits antibodies to group b streptococcus conjugated to a c protein alpha antigen or beta antigen of said group b streptococcus
10/13/1998	US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting
10/13/1998	US5820847 Administering a diagnostic agent complexed with a targeting ligand of folates or receptor-binding derivatives; for transporting exogenous molecules into cells with folate receptors; drug delivery
10/13/1998	US5820632 Prepared calcium phosphate composition and method
10/08/1998	WO1998044143A1 Polymer-modified viruses
10/08/1998	WO1998044024A1 Polymers with thiol terminal function
10/08/1998	WO1998044021A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	WO1998044001A1 High avidity polyvalent and polyspecific reagents
10/08/1998	WO1998043694A1 Targeted therapy to a biomedical device
10/08/1998	WO1998043677A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/08/1998	WO1998043676A1 Phospholipid drug derivatives
10/08/1998	WO1998043675A1 Oral pharmaceutical preparations decreased in bitterness by masking
10/08/1998	WO1998043674A1 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof
10/08/1998	WO1998043673A1 Solvent system for enhanced penetration of pharmaceutical compounds
10/08/1998	WO1998043664A1 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
10/08/1998	WO1998043643A1 Aqueous acyclovir solution preparations
10/08/1998	WO1998043636A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043635A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
10/08/1998	WO1998043633A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory
10/08/1998	WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis
10/08/1998	WO1998043615A1 Method for oral delivery of proteins
10/08/1998	WO1998043614A1 Drug preparations for treating sexual dysfunction
10/08/1998	WO1998043613A1 Ointments for treating suppurative lesions, burns and trophic ulcers at all stages, preparation and applications of same
10/08/1998	WO1998043611A1 Diffusional implantable delivery system
10/08/1998	WO1998043610A1 A method for producing jelly sweets which contain antibodies
10/08/1998	WO1998043609A2 Chitosane microspheres

1 ... 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 ... 1712